Oppenheimer’s Equities Division strives to create exceptional value for our corporate and institutional clients. Our goal is to be the premier research, trading, and capital solutions firm for the markets we serve.
Our core capabilities include:
- A research department of more than 100 research professionals providing coverage of over almost 600 companies across a wide range of industries, with a particular focus on mid- and small-cap companies
- Over 75 institutional sales professionals operating throughout the U.S., U.K., Israel, Asia, and Europe through various affiliates
- A global trading platform that provides execution in all venues and on numerous exchanges throughout the world
- An Equity Capital Markets Group that offers innovative and comprehensive capital markets solutions
In addition to these capabilities, we offer specialized service and expertise in portfolio trading, event and merger arbitrage, convertible securities, SPACs, UIT’s, closed end funds, Derivatives and ETFs.
Conferences & Events
Oppenheimer hosts multiple conferences a year covering many different industries. These conferences bring together corporate leaders, financial sponsors and institutional investors to explore market and sector trends.Learn more
The mission of Oppenheimer’s Equity Research department is to provide thoughtful, insightful and differentiated research so that our clients can make informed investment decisions.
Sales & Trading
Oppenheimer Institutional Sales and Trading offers the highest level of client service for equity portfolio managers and analysts.
- Joint Bookrunner
- Gain Therapeutics Inc